News
Navigo Proteins appoints Dr. Florian Settele as Managing Director of Navigo Pure
Navigo Proteins Announces Strategic R&D Collaboration with SCK CEN to Develop Targeted Radiotheranostics
Navigo Proteins and VERAXA Biotech Initiate Research Collaboration to Establish Pre-Targeting Strategies for Novel Affilin® Radio Conjugates
Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19
Navigo Proteins Successfully Develops Affinity Resin against Ferritin for blood fraction processing
Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies
Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin Customized for the Efficient Purification of Human Complement-Factor H